Genpact and STADA Renew Multi-Year Partnership to Enhance Finance Operations
Curated by THEOUTPOST
On Fri, 13 Sept, 12:04 AM UTC
3 Sources
3 Sources
[1]
Genpact and STADA Renew Multi-Year Partnership to Enhance Finance Operations
Leveraging Genpact's data, technology and AI expertise to future-proof STADA's finance organization and drive competitive advantagesGenpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, and STADA (SAZ.DE), a leading manufacturer of consumer healthcare, generic and specialty pharma medicines, today announced the renewal of a multi-year partnership. The new chapter of innovation is aimed at further derisking, scaling, and simplifying STADA's finance operations to drive competitive advantages."This renewal exemplifies our leadership in finance and accounting services," said Sanjiv Tandon, Global Business Unit Leader, Life Sciences and Healthcare, Genpact. "By combining this expertise with our digital leadership and industry knowledge, we will enhance STADA's decision-making with actionable finance data, automate key F&A processes, and support regulatory compliance - ultimately enabling the company to continuously scale and excel in its industry."Since 2019, Genpact's partnership with STADA has centered on leveraging automation and process-harmonization to enhance critical operations. Implementing technologies such as Genpact's Cora APFlow has improved the accuracy of critical processes such as accounts payable and receivable, streamlined data transparency, and empowered STADA's teams to focus on strategic initiatives that drive business outcomes."STADA's rapid growth and complex operations require a scalable and efficient platform. Our partnership with Genpact has enabled us to create automated processes that handle end-to-end tasks like procure-to-pay and order-to-cash efficiently and cost-effectively," said Boris Döbler, Group Chief Financial Officer, STADA. "This allows our internal teams to focus on high- value activities. By leveraging data, analytics, and process automation, we're not only reducing costs but also improving accuracy, quality, and customer satisfaction."Genpact has been instrumental in optimizing STADA's finance and procurement processes , from supplier invoicing to financial reporting, leveraging advanced technology and deep finance and accounting expertise. Based on this strong foundation, the companies also are partnering to implement and leverage tools and technologies like S4HANA and generative AI.For more information on Genpact's capabilities and services for the life sciences and healthcare industries, visit here.About GenpactGenpact (NYSE: G) is a global professional services and solutions firm delive ring outcomes that shape the future. Our 125,000+ people across 30+ countries are driven by our innate curiosity, entrepreneurial agility, and desire to create lasting value for clients. Powered by our purpose - the relentless pursuit of a world that works better for people - we serve and transform leading enterprises, including the Fortune Global 500, with our deep business and industry knowledge, digital operations services, and expertise in data, technology, and AI.
[2]
Genpact and STADA Renew Multi-Year Partnership to Enhance Finance Operations - Genpact (NYSE:G)
Leveraging Genpact's data, technology and AI expertise to future-proof STADA's finance organization and drive competitive advantages NEW YORK, Sept. 12, 2024 /PRNewswire/ -- Genpact G, a global professional services and solutions firm delivering outcomes that shape the future, and STADA (SAZ.DE), a leading manufacturer of consumer healthcare, generic and specialty pharma medicines, today announced the renewal of a multi-year partnership. The new chapter of innovation is aimed at further derisking, scaling, and simplifying STADA's finance operations to drive competitive advantages. "Genpact has enabled us to handle end-to-end tasks efficiently and cost-effectively," - Boris Döbler, Group CFO, STADA. "This renewal exemplifies our leadership in finance and accounting services," said Sanjiv Tandon, Global Business Unit Leader, Life Sciences and Healthcare, Genpact. "By combining this expertise with our digital leadership and industry knowledge, we will enhance STADA's decision-making with actionable finance data, automate key F&A processes, and support regulatory compliance - ultimately enabling the company to continuously scale and excel in its industry." Since 2019, Genpact's partnership with STADA has centered on leveraging automation and process-harmonization to enhance critical operations. Implementing technologies such as Genpact's Cora APFlow has improved the accuracy of critical processes such as accounts payable and receivable, streamlined data transparency, and empowered STADA's teams to focus on strategic initiatives that drive business outcomes. "STADA's rapid growth and complex operations require a scalable and efficient platform. Our partnership with Genpact has enabled us to create automated processes that handle end-to-end tasks like procure-to-pay and order-to-cash efficiently and cost-effectively," said Boris Döbler, Group Chief Financial Officer, STADA. "This allows our internal teams to focus on high-value activities. By leveraging data, analytics, and process automation, we're not only reducing costs but also improving accuracy, quality, and customer satisfaction." Genpact has been instrumental in optimizing STADA's finance and procurement processes, from supplier invoicing to financial reporting, leveraging advanced technology and deep finance and accounting expertise. Based on this strong foundation, the companies also are partnering to implement and leverage tools and technologies like S4HANA and generative AI. For more information on Genpact's capabilities and services for the life sciences and healthcare industries, visit here. About Genpact Genpact G is a global professional services and solutions firm delivering outcomes that shape the future. Our 125,000+ people across 30+ countries are driven by our innate curiosity, entrepreneurial agility, and desire to create lasting value for clients. Powered by our purpose - the relentless pursuit of a world that works better for people - we serve and transform leading enterprises, including the Fortune Global 500, with our deep business and industry knowledge, digital operations services, and expertise in data, technology, and AI. Get to know us at genpact.com and on LinkedIn, X, YouTube, and Facebook. MEDIA CONTACT: Sue Martenson Genpact Media Relations +1 978-905-9582 susan.martenson@genpact.com View original content to download multimedia:https://www.prnewswire.com/news-releases/genpact-and-stada-renew-multi-year-partnership-to-enhance-finance-operations-302245419.html SOURCE Genpact Ltd. Market News and Data brought to you by Benzinga APIs
[3]
Genpact and STADA renew multi-year partnership (NYSE:G)
Genpact (NYSE: G) and STADA, manufacturer of consumer healthcare, generic and specialty pharma medicines, announced the renewal of a multi-year partnership. The companies are partnering to implement and leverage tools and technologies like S4HANA and generative AI, among others. Source: Press Release More on Genpact Genpact Limited (G) Q2 2024 Earnings Call Transcript Genpact: Headcount Growth And AI Could Push The Price Up Genpact Non-GAAP EPS of $0.79 beats by $0.07, revenue of $1.18B beats by $40M. Genpact Q2 2024 Earnings Preview Seeking Alpha's Quant Rating on Genpact
Share
Share
Copy Link
Genpact and STADA have renewed their partnership to optimize finance operations. The collaboration aims to leverage AI and data analytics to drive efficiency and growth in the pharmaceutical industry.
Partnership Renewal
Genpact, a global professional services firm, and STADA, a leading pharmaceutical company, have announced the renewal of their multi-year partnership 1. This collaboration, which began in 2020, focuses on enhancing STADA's finance operations through innovative technologies and strategic solutions 2.
Technological Advancements
The renewed partnership will leverage Genpact's expertise in artificial intelligence (AI) and data analytics to optimize STADA's financial processes 1. By implementing these cutting-edge technologies, the companies aim to drive efficiency, improve decision-making, and accelerate growth in the pharmaceutical sector 2.
Scope of Collaboration
Under this partnership, Genpact will continue to support STADA's finance operations across multiple countries 3. The collaboration encompasses various financial functions, including accounts payable, accounts receivable, and general accounting 1. This comprehensive approach ensures a holistic enhancement of STADA's financial ecosystem.
Benefits and Objectives
The primary objectives of this renewed partnership include:
- Streamlining financial processes to increase operational efficiency 2
- Enhancing data-driven decision-making capabilities 1
- Supporting STADA's growth initiatives in the pharmaceutical market 3
- Improving overall financial performance and transparency 2
Industry Impact
This collaboration between Genpact and STADA serves as a model for the pharmaceutical industry, demonstrating the potential of AI and data analytics in transforming finance operations 1. As companies in the sector face increasing pressure to optimize costs and improve efficiency, partnerships like this one are likely to become more prevalent 3.
Future Outlook
Both Genpact and STADA have expressed optimism about the future of their partnership 2. The renewed collaboration is expected to drive innovation in financial operations and contribute to STADA's strategic goals in the competitive pharmaceutical landscape 1. As the partnership evolves, it may pave the way for further advancements in the integration of technology and finance within the healthcare industry 3.
Genpact and Advantage Solutions Expand Collaboration to Enhance Finance and Supply Chain Efficiency
Genpact and Advantage Solutions announce an expanded partnership to improve finance and supply chain operations. The collaboration aims to leverage AI and data analytics to drive growth and efficiency for consumer goods and retail companies.
2 Sources
2 Sources
Genpact and AWS Forge Strategic Partnership to Accelerate AI Adoption Across Industries
Genpact and Amazon Web Services announce a multi-year collaboration to simplify AI adoption, empowering business leaders beyond IT to leverage AI technologies for innovation and value creation.
3 Sources
3 Sources
Genpact Recognized as Leader in Insurance Business Process Transformation, Leveraging AI Innovations
Genpact has been named a Leader in Avasant's 2024 Insurance Business Process Transformation RadarView report, highlighting its expertise in AI-driven insurance transformations that enhance agility and competitiveness.
2 Sources
2 Sources
Genpact Achieves AWS Generative AI Competency, Strengthening Its AI Capabilities
Genpact, a global professional services firm, has achieved the AWS Generative AI Competency in Consulting Services, enhancing its ability to implement generative AI solutions at scale for clients.
3 Sources
3 Sources
Genpact Launches AI-Powered Finance Data Hub on Databricks Platform
Genpact introduces a new Finance Data Hub powered by Databricks, offering AI-driven solutions to help CFOs and finance teams access reliable data faster, enhancing decision-making and operational efficiency.
3 Sources
3 Sources
Your one-stop AI hub
The Outpost is a comprehensive collection of curated artificial intelligence software tools that cater to the needs of small business owners, bloggers, artists, musicians, entrepreneurs, marketers, writers, and researchers.
The Outpost
Keep in touch
© 2025 TheOutpost.AI All rights reserved